The role and mechanism of NAT10‐mediated ac4C modification in tumor development and progression
MedComm · 2024-12 · 5 (12)
DOI: 10.1002/mco2.70026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 04.12.2024. Verfasst von Zhuoran Gu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Shanghai Tenth People's Hospital School of Medicine Tongji University Shanghai China. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
RNA modification has emerged as a crucial area of research in epigenetics, significantly influencing tumor biology by regulating RNA metabolism. N‐acetyltransferase 10 (NAT10)‐mediated N4‐acetylcytidine (ac4C) modification, the sole known acetylation in eukaryotic RNA, influences cancer pathogenesis and progression. NAT10 is the only writer of ac4C and catalyzes acetyl transfer on targeted RNA, and ac4C helps to improve the stability and translational efficiency of ac4C‐modified RNA. NAT10 is highly expressed and associated with poor prognosis in pan‐cancers. Based on its molecular mechanism and biological functions, ac4C is a central factor in tumorigenesis, tumor progression, drug resistance, and tumor immune escape. Despite the increasing focus on ac4C, the specific regulatory mechanisms of ac4C in cancer remain elusive. The present review thoroughly analyzes the current knowledge on NAT10‐mediated ac4C modification in cancer, highlighting its broad regulatory influence on targeted gene expression and tumor biology. This review also summarizes the limitations and perspectives of current research on NAT10 and ac4C in cancer, to identify new therapeutic targets and advance cancer treatment strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology Shanghai Tenth People's Hospital School of Medicine Tongji University Shanghai China.
- Urologic Cancer Institute School of Medicine Tongji University Shanghai China.
- Tongji University Cancer Center, Shanghai Tenth People's Hospital, School of Medicine Tongi University Shanahai China.
ORCID-Profile: Bing Shen
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Gu, Z., Zou, L., Pan, X., Yu, Y., Liu, Y., Zhang, Z., Liu, J., Mao, S., Zhang, J., Guo, C., Li, W., Geng, J., Zhang, W., Yao, X., & Shen, B. (2024). The role and mechanism of NAT10‐mediated ac4C modification in tumor development and progression. MedComm, 5(12). https://doi.org/10.1002/mco2.70026
Vancouver
Gu Z, Zou L, Pan X, Yu Y, Liu Y, Zhang Z, et al. The role and mechanism of NAT10‐mediated ac4C modification in tumor development and progression. MedComm. 2024;5(12). doi:10.1002/mco2.70026
BibTeX
@article{Gu2024,
author = {Gu, Zhuoran and Zou, Libin and Pan, Xinjian and Yu, Yang and Liu, Yongqiang and Zhang, Zhijin and Liu, Ji and Mao, Shiyu and Zhang, Junfeng and Guo, Changcheng and Li, Wei and Geng, Jiang and Zhang, Wentao and Yao, Xudong and Shen, Bing},
title = {The role and mechanism of NAT10‐mediated ac4C modification in tumor development and progression},
journal = {MedComm},
year = {2024},
volume = {5},
number = {12},
doi = {10.1002/mco2.70026}
}
EUVIMED